Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Molecular Imaging
|
October 18, 2017
First-in-Man Evaluation of <sup>124</sup>I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
Richard Laforest, Farrokh Dehdashti, Yongjian Liu, et al.
The European Respiratory Journal
|
January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis
David S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
Molecular Imaging and Biology
|
May 6, 2016
[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
Richard Laforest, Suzanne E Lapi, Reiko Oyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate
Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Molecular Imaging
|
October 18, 2017
First-in-Man Evaluation of <sup>124</sup>I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
Richard Laforest, Farrokh Dehdashti, Yongjian Liu, et al.
The European Respiratory Journal
|
January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis
David S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
Molecular Imaging and Biology
|
May 6, 2016
[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
Richard Laforest, Suzanne E Lapi, Reiko Oyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2024
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate
Jessica Pougoue Ketchemen, Fabrice Ngoh Njotu, Hanan Babeker, et al.
Page
of 2